Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

Macy’s Faces Critical Test with Upcoming Q2 Earnings Report

Felix Baarz by Felix Baarz
August 31, 2025
in Consumer & Luxury, Earnings, Turnaround
0
Macy's Stock
0
SHARES
220
VIEWS
Share on FacebookShare on Twitter

All eyes are on Macy’s as the struggling retail giant prepares to release its second-quarter financial results next week. The report arrives amid lowered expectations and dimmed forecasts, presenting a crucial moment for the company’s ongoing turnaround efforts.

The company is scheduled to announce its quarterly performance before markets open on Wednesday, September 3rd. Market experts anticipate revenue to fall within a range of $4.69 to $4.74 billion, with projected earnings of $0.19 per share. Macy’s continues to navigate a complex landscape marked by trade tariffs, cautious consumer spending, and intense retail sector competition.

In a move that signaled persistent headwinds, Macy’s management had already tempered its full-year 2025 guidance. The company revised its annual profit forecast downward to a range of $1.60 to $2.00 per share. However, its revenue outlook for the year remained steady, maintained at $21.0 to $21.4 billion.

Should investors sell immediately? Or is it worth buying Macy's?

Turnaround Strategy Under Scrutiny

The core of the company’s future hinges on its ambitious “Bold New Chapter” restructuring plan. This radical strategy involves closing 150 underperforming locations by 2026 while simultaneously modernizing and expanding 125 of its most promising stores. Early indicators from the first quarter showed some positive momentum: credit card revenue surged by an impressive 31.6% to $154 million, and the gross margin held firm at 39.2%.

Despite these glimmers of progress, market sentiment remains largely skeptical. The average analyst price target for Macy’s stock sits around $13.22, only marginally above its current trading level. Sentiment among researchers is cautious; out of twelve analysts covering the stock, nine currently advise holding, while just one recommends buying.

For income-focused investors, the recent dividend payment of $0.1824 per share provides a modest silver lining. The central question, however, is whether this can offset the deeper structural issues the retailer faces. The upcoming quarterly figures will be pivotal in determining if Macy’s can finally initiate the long-awaited recovery or if it will confirm the market’s most pessimistic fears.

Ad

Macy's Stock: Buy or Sell?! New Macy's Analysis from December 3 delivers the answer:

The latest Macy's figures speak for themselves: Urgent action needed for Macy's investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.

Macy's: Buy or sell? Read more here...

Tags: Macy's
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Ballard Power Stock
Analysis

Is Ballard Power Stock Nearing an Inflection Point?

December 3, 2025
Innovative Industrial Properties Stock
Analysis

Is Innovative Industrial Properties a Deep-Value Cannabis Play?

December 3, 2025
Nio Stock
Analysis

Nio’s Stock Dilemma: Record Deliveries Meet Investor Skepticism

December 3, 2025
Next Post
Costco Stock

Costco's Bold Membership Strategy: Rewarding Premium Customers

Marin Software Stock

Marin Software's Nasdaq Exit Culminates in Chapter 11 Restructuring and Shareholder Wipeout

Lufax Holding Stock

Leadership Shifts and Dividend Impact at Lufax Amid Trading Halt

Recommended

Capital One Stock

Major Institutions Back Capital One Despite Acquisition Costs

3 months ago
Coca-Cola Stock

Coca-Cola Stock: A Dual-Pronged Growth Strategy Takes Shape

1 week ago
Summit Therapeutics Stock

Summit Therapeutics: Clinical Data Divides Market as CEO Backs Conviction

3 months ago
SunHydrogen Stock

SunHydrogen Reaches Commercial Milestone with First Revenue

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

Netflix Stock: Aggressive Expansion Strategy Takes Shape

Is Innovative Industrial Properties a Deep-Value Cannabis Play?

Is Alibaba’s Stock Dip a Strategic Entry Point?

Intellia Therapeutics Faces Critical Juncture Following Clinical Trial Death

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures

by Robert Sasse
December 3, 2025
0

The year 2025 is shaping up to be a formidable challenge for Novo Nordisk, with its share...

Ballard Power Stock

Is Ballard Power Stock Nearing an Inflection Point?

December 3, 2025
Redcare Pharmacy Stock

Redcare Pharmacy Shares Continue Their Steep Descent

December 3, 2025
Bionxt Solutions Stock

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

December 3, 2025
European Lithium Stock

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures
  • Is Ballard Power Stock Nearing an Inflection Point?
  • Redcare Pharmacy Shares Continue Their Steep Descent

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com